Consistent with our results, other studies also demonstrated that GAD-specific CD4+ T cells from NOD mice, or CD4+ T cells from transgenic mice (expressing TCRs derived from NOD mouse T cell hybridomas specific for GAD peptides) inhibited T1D [28],[29]. Here, CD4 is linked to type 1 diabetes mellitus.